Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Payables (2018 - 2023)

Avai Bio's Payables history spans 5 years, with the latest figure at $1.1 million for Q4 2023.

  • For Q4 2023, Payables rose 346.59% year-over-year to $1.1 million; the TTM value through Dec 2023 reached $1.1 million, up 346.59%, while the annual FY2023 figure was $531501.0, N/A changed from the prior year.
  • Payables for Q4 2023 was $1.1 million at Avai Bio, up from $308010.0 in the prior quarter.
  • Across five years, Payables topped out at $1.2 million in Q3 2020 and bottomed at $3800.0 in Q4 2019.
  • The 4-year median for Payables is $237221.0 (2022), against an average of $329334.4.
  • The largest annual shift saw Payables surged 13165.87% in 2020 before it rose 29.84% in 2023.
  • A 4-year view of Payables shows it stood at $3800.0 in 2019, then soared by 13165.87% to $504103.0 in 2020, then crashed by 49.12% to $256501.0 in 2022, then skyrocketed by 346.59% to $1.1 million in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Payables are $1.1 million (Q4 2023), $308010.0 (Q3 2023), and $415610.0 (Q2 2023).